Global Wearable Injectors Market Scope 2024, Forecast To 2033
22 Jan, 2024
The wearable injectors market has grown rapidly, increasing from $8.04 billion in 2023 to $9.07 billion in 2024, with a 12.9% CAGR. Historical factors include chronic disease management, patient convenience, technological advancements, and an aging population. Forecasts suggest rapid growth, reaching $15.23 billion by 2028, with a 13.8% CAGR. The forecasted period emphasizes personalized medicine, remote patient monitoring, drug development, and chronic disease management. Major trends include biologics, dual-chamber wearables, connected devices, and patch pump technology.
Global Wearable Injectors Market Key Driver
The wearable injectors market experiences growth driven by the increasing number of diabetic and chronic disease patients. The International Diabetes Federation reported that in 2021, approximately 537 million adults lived with diabetes, with an estimated 783 million expected by 2045. The surge in diabetes and chronic diseases amplifies the demand for disease treatment, fostering growth in the wearable injectors market.
Get A Free Sample Of The Global Wearable Injectors Market ReportGlobal Wearable Injectors Market Segments
The wearable injectors market covered in this report is segmented –
1) By Type: On-Body Injectors, Off-Body Injectors
2) By End-User: Hospitals, Clinics, Homecare setting
3) By Application: Immuno-Oncology, Diabetes, Cardiovascular Diseases, Other Applications
By Geography: The regions covered in the wearable injectors market report are Asia-Pacific, Western Europe, Eastern Europe,North America, South America, Middle East, and Africa. Among these regions
North America was the largest region in the wearable injectors market in 2023. Western Europe was the second-largest region in the wearable injectors market analysis. The regions covered in the wearable injectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Major Wearable Injectors Industry Players
Amgen Inc., Becton Dickinson and Company (BD), Enable Injections LLC, Insulet Corporation, Ypsomed Holding AG, Medtronic MiniMed Inc., Tandem Diabetes Care Inc., Valeritas Inc., West Pharmaceutical Services Inc., Sensile Medical AG, Gerresheimer AG, Dexcom Inc., Consort Medical plc, United Therapeutics Corporation, Bühler Motor GmbH, Debiotech SA, Cellnovo Group, EoFlow Co. Ltd., CeQur SA, Haselmeier AG, Johnson & Johnson, kaleo Inc., Mylan N.V., Nemera Development S.A., F. Hoffmann-La Roche Ltd, Zosano Pharma Corporation
Get The Full Global Wearable Injectors Market Report
Wearable Injectors Market Overview
Wearable injectors are drug delivery devices that adhere to the body while the drug is administered subcutaneously over a preset time period.
Wearable Injectors Global Market Report 2023 provides data on the global wearable injectors market such as market size, growth forecasts, segments and geographies, competitive landscape including leading competitors’ revenues, profiles and market shares. The wearable injectors market report identifies opportunities and strategies based on market trends and leading competitors’ approaches.